RE: An Assumption!27 Aug 2020 09:36
....you might want to be reminded that the RNS of 22nd June, this time with Aptamer Group, said basically the same thing:
"A pilot batch of the aptamers will be tested on Integumen's SARS-CoV-2 model virus. Once initial testing is complete in two months, validation on the real SARS-CoV-2 virus will be carried out at the containment level 3 ("CL3") laboratory in the University of Aberdeen."
Both these show that SKIN are trialing Aptamers and Affirmers for Microtox NS. In the AVCT situation: "Affimers into Integumen's sensors which will initially be integrated and retrofitted into Modern Water plc's Microtox water contamination system units to detect the coronavirus. The Microtox system, which can detect the presence of contaminating bacteria, virus and toxins but not yet identify them, is distributed by Modern Water and has a global footprint of over 3,000 installations."
For the Aptamer situation: "Integumen and the Aptamer Group will enter into a longer-term supply agreement, with Integumen manufacturing and commercialising real-time pathogenic virus and bacteria detection devices through its production, sales, marketing and distribution channel partners around the world."
So I think the Aberdeen testing won't start till around now "two months", we have no indication of how long it will take, but when it does happen, one/other or both of these innovations may well have significant traction. IMO, DYOR etc, but the above "" are just out of the respective RNSs.